Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/29 04:58:30 pm
132.475 EUR   -1.69%
12:41pMERCK : Mammoth Biosciences Partner to Produce, Scale Up Covid-19 Test
DJ
10/28MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
10/28MERCK : to Invest EUR20 Million in Display-Technology Production
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 108.05 EUR
Weaknesses
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's enterprise value to sales, at 4.01 times its current sales, is high.
  • The company benefits from high valuations in earnings multiples.
  • The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Sector Specialty & Advanced Pharmaceuticals
1st jan.Capitalisation (M$)Investor Rating
MERCK KGAA27.91%68 876
ZHANGZHOU PIENTZEHUANG PHAR..114.34%20 946
KYOWA KIRIN CO., LTD.3.03%13 754
BETTA PHARMACEUTICALS CO., ..69.71%6 490
YUHAN CORPORATION29.39%3 340
RECIPHARM AB (PUBL)9.93%1 645
INDIVIOR172.05%1 010
KISSEI PHARMACEUTICAL CO., ..-32.44%949
SUPERNUS PHARMACEUTICALS, I..-25.38%932
NICHI-IKO PHARMACEUTICAL CO..-22.04%650
DONG-A ST CO., LTD.-28.57%649
CALLIDITAS THERAPEUTICS AB ..41.88%607
KNIGHT THERAPEUTICS INC.-27.44%538
ASSEMBLY BIOSCIENCES, INC.-27.08%490
CHONG KUN DANG HOLDINGS COR..-2.87%436
MAYNE PHARMA GROUP LIMITED-29.89%368
More Results
Financials
Sales 2020 17 303 M 20 175 M 20 175 M
Net income 2020 1 724 M 2 010 M 2 010 M
Net Debt 2020 10 812 M 12 607 M 12 607 M
P/E ratio 2020 32,4x
Yield 2020 0,99%
Capitalization 58 586 M 68 876 M 68 309 M
EV / Sales 2020 4,01x
EV / Sales 2021 3,72x
Nbr of Employees 57 523
Free-Float 29,7%
Upcoming event on MERCK KGAA
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes